EU regulator recommends clearing Takeda’s dengue vaccine
New omicron subvariant largely evades neutralizing antibodies
14 October 2022Engineering a solution to a skin-deep problem of blood oxygen measurements
14 October 2022EU regulator recommends clearing Takeda’s dengue vaccine
The European Medicines Agency on Friday recommended the authorization of a dengue vaccine made by the Japanese pharmaceutical Takeda that could provide a new tool for millions worldwide against the potentially fatal disease.
